當(dāng)前位置 ： Millipore >>> Millipore/MAB3420 | Anti-Tau-1 Antibody, clone PC1C6/MAB3420/100 µg
Millipore/MAB3420 | Anti-Tau-1 Antibody, clone PC1C6/MAB3420/100 µg
  • Millipore/MAB3420 | Anti-Tau-1 Antibody, clone PC1C6/MAB3420/100 µg

Millipore/MAB3420 | Anti-Tau-1 Antibody, clone PC1C6/MAB3420/100 µg

價格: ￥4680.00 市場價: 7800.00
貨號: MAB3420
品牌: Millipore
規(guī)格
數(shù)量
庫存(0)
特別 提示
代購產(chǎn)品：無質(zhì)量問題不接受退換貨，下單前請仔細(xì)核對信息。
下單后請及時聯(lián)系客服核對商品價格，訂單生效后再付款。
資深產(chǎn)品顧問
咨詢顧問

全國免費(fèi)服務(wù)熱線

4000-520-616

  • 自營商城 一站式服務(wù)
  • 廠家直采 剔除溢價
  • 品質(zhì)甄選 正品保證
  • 嚴(yán)控流程 只做188精品
  • 極速物流 如約送貨
  • 詳情
  • 使用說明
  • 常見問題
    • Description
      CatalogueNumberMAB3420
      ReplacesAB1512
      BrandFamilyChemicon®
      TradeName
      • Chemicon
      DescriptionAnti-Tau-1Antibody,clonePC1C6
      BackgroundInformationTau,amicrotubulebindingproteinwhichservestostABIlizemicrotubulesingrowingaxons,isfoundtobehyperphosphorylatedinpairedhelicalfilaments(PHF),themajorfibrouscomponentofneurofibrillarylesionsassociatedwithAlzheimer’sdisease.HyperphosphorylationofTauisthoughttobethecriticaleventleADIngtotheassemblyofPHF.SixTauproteinisoformshavebeenidentified,allofwhicharephosphorylatedbyglycogensynthasekinase3(GSK3).Cellularandsubcellularlocalization:Insitu,anti-tau-1hasastringentspecificityfortheaxonsofneurons.Theantibodydoesnotstainthecellbodiesordendritesofneurons,nordoesitstainanyothercelltype(4).However,thisinvivointracellularspecificityisnotmaintainedinculture:anti-tau-1stainstheaxon,cellbodies,anddendritesofrathippocampalneuronsgrowninculture(5).Thespecificityofanti-tau-1wasoriginallythoughttorepresenttherestrictedexpressionoftautoaxons.Laterstudiesrevealedthatthisspecificityisdependantonthestateofphosphorylation.Indephosphorylatedsamples(samplestreatedwithalkalinephosphatase)anti-tau-1stainsastrocytes,perineuronalglialcells,andtheaxons,cellbodiesanddendritesofneurons,whileinuntreatedsamples,anti-tau-1stainsonlyaxons(6).(Theepitoperecognizedbyanti-tau-1isprobablyatornearaphosphorylatedsite.)
      ProductInformation
      FormatPurified
      Control
      • Alzheimer"sbraintissue(dephosphorylationwithalkalinephosphataseisrecommendedforstainingneurofibrillarytanglesinAlzheimer’sbraintissue)orhumanT98Gglioblastomacells
      Presentation0.02Mphosphatebuffer,pH7.6,0.25MNaCl,and0.1%sodiumazide
      StorageandShippingInformation
      StorageConditionsMaintainfor1yearat-20°Cfromdateofshipment.Aliquottoavoidrepeatedfreezingandthawing.Formaximumrecoveryofproduct,centrifugetheoriginalvialafterthawingandpriortoremovingthecap.
      Applications
      ApplicationAnti-Tau-1Antibody,clonePC1C6isanantibodyagainstTau-1foruseinIH&WBwithmorethan65productcitations.
      KeyApplications
      • Immunohistochemistry
      • WesternBlotting
      ApplicationNotesWesternblot:Bovinebrainmicrotubuleproteinspurifiedbytwocyclesofassemblyanddisassembly(9)aredissolvedinSDS-PAGEsamplebuffer.Fivemicrogramsofthemicrotublepreparationperlaneisloadedontoa4%to20%SDS-PAGEgradientgelalongsidemolecularweightMarkers(14.3-200kD).Afterseparationbyelectrophoresis,theproteinsareblottedontonitrocellulose.Tauisdetectedasaseriesof5bands(52-68kD)withapproximately5ng/mLofanti-tau-1.

      Immunohistochemistry:5μg/mL;stainsaxonsintissueprimarily,howeverincultureTauexpressionisnotrestrictedtojustaxons.

      Optimalworkingdilutionsmustbedeterminedbyenduser.

      ImmunohistochemistryProtocol

      Dephosphorylationoftissuesections(optional)

      DephosphorylationwithalkalinephosphataseisrecommendedforstainingneurofibrillarytanglesinAlzheimer"sbraintissuewithanti-tau-1(6).Thistreatmentchangesthestainingpatternofanti-tau-1toincludecellbodies,dendritesandaxonsofneurons.Inuntreatedsamples,anti-tau-1stainsaxonsonly.

      1.Incubatetissuesectionsat+32°Cfor2.5hourswithconstantagitationinthefollowingsolution:100mMTris-HCl,pH8.0;130units/mLalkalinephosphatase,1mMPMSF,10μg/mLpepstatinand10μg/mLleupeptin.

      2.Rinsesectionstwice,3minperrinse,with100mMTris-HCl,pH8.0.

      Anti-tau-1staining

      1.Blocknon-specificbindingbyincubatingsectionsinPBScontaining1%(v/v)normalanimalserum,and0.03%(w/v)TritonX-100.Theanimalserumshouldbefromthesamespeciesasthesecondaryantibody.

      2.Rinse3timeswithPBS,3minperrinse.

      3.Incubatesectionswithanti-tau-1,approximately5μg/mL,dilutedinPBScontaining1%(v/v)normalanimalserum.

      4.WashwithPBS,changingthesolution3timesovera3minperiod.

      5.Detectwithastandardsecondaryantibodydetectionsystem(10-13).
      BIOLOGicalInformation
      ImmunogenPurifieddenaturedbovinemicrotubuleassociatedproteins.
      ClonePC1C6
      ConcentrationPleaserefertotheCertificateofAnalysisforthelot-specificconcentration.
      HostMouse
      SpecificityBindstoallknownelectrophoreticspeciesoftauinhuman,ratandbovinebrain(one-dimensionalSDS-PAGE).HoweverthereissomeunphosphorylatedbiaswithclonePC1C6asitseemtorecognizeonlydephosphorylatedserinesitesat195,198,199,and202{Szendrei,etal1993;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi-cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=7680727}.AlsoseeBillingsley&Kincaid,1997BiochemJ323:577-591foradditionalmappinginformationonPC1C6.
      IsotypeIgG2a
      SpeciesReactivity
      • Bovine
      • Human
      • Rat
      AntibodyTypeMonoclonalAntibody
      EntrezGeneNumber
      EntrezGeneSummaryThisgeneencodesthemicrotubule-associatedproteintau(MAPT)whosetranscriptundergoescomplex,regulatedalternativesplicing,givingrisetoseveralmRNAspecies.MAPTtranscriptsaredifferentiallyexpressedinthenervoussystem,dependingonstageofneuronalmaturationandneurontype.MAPTgenemutationshavebeenassociatedwithseveralneurodegenerativedisorderssuchasAlzheimer"sdisease,Pick"sdisease,frontotemporaldementia,cortico-basaldegenerationandprogressivesupranuclearpalsy.
      GeneSymbol
      • MAPT
      • MTBT2
      • MAPTL
      • tau
      • FTDP-17
      • MSTD
      • TAU
      • FLJ31424
      • MTBT1
      • PHF-tau
      • DDPAC
      • MGC138549
      • PPND
      PurificationMethodProteinAPurfied
      UniProtNumber
      UniProtSummaryFUNCTION:SwissProt:P10636#Promotesmicrotubuleassemblyandstability,andmightbeinvolvedintheestablishmentandmaintenanceofneuronalpolarity.TheC-terminusbindsaxonalmicrotubuleswhiletheN-terminusbindsneuralplasmamembranecomponents,suggestingthattaufunctionsasalinkerproteinbetweenboth.Axonalpolarityispredeterminedbytaulocalization(intheneuronalcell)inthedomainofthecellbodydefinedbythecentrosome.TheshortisoformsallowplasticityoftheCytoskeletonwhereasthelongerisoformsmaypreferentiallyplayaroleinitsstabilization.
      SIZE:758aminoacids;78878Da
      SUBUNIT:InteractswithPSMC2throughSQSTM1(Bysimilarity).InteractswithSQSTM1whenpolyubiquitinated.
      SUBCELLULARLOCATION:Cytoplasm,cytosol.Cellmembrane.Note=Mostlyfoundintheaxonsofneurons,inthecytosolandinassociationwithplasmamembranecomponents.
      TISSUESPECIFICITY:Expressedinneurons.IsoformPNS-tauisexpressedintheperipheralnervoussystemwhiletheothersareexpressedinthecentralnervoussystem.DEVELOPMENTALSTAGE:Four-repeat(typeII)tauisexpressedinanadult-specificmannerandisnotfoundinfetalbrain,whereasthree-repeat(typeI)tauisfoundinbothadultandfetalbrain.
      DOMAIN:SwissProt:P10636Thetau/MAPrepeatbindstotubulin.TypeIisoformscontain3repeatswhiletypeIIisoformscontain4repeats.
      PTM:PhosphorylationatserineandthreonineresiduesinS-PorT-Pmotifsbyproline-directedproteinkinases(PDPK:CDC2,CDK5,GSK-3,MAPK)(only2-3sitesperproteinininterphase,seven-foldincreaseinmitosis,andinPHF-tau),andatserineresiduesinK-X-G-SmotifsbyMAP/microtubuleaffinity-regulatingkinase(MARK)inAlzheimerdiseasedbrains.Phosphorylationdecreaseswithage.Phosphorylationwithintau"srepeatdomainorinflankingregionsseemstoreducetau"sinteractionwith,respectively,microtubulesorplasmamembranecomponents.PhosphorylationonSer-610,Ser-622,Ser-641andSer-673inseveralisoformsduringmitosis.&Polyubiquitinated.RequiresfunctionalTRAF6andmayprovokeSQSTM1-dependentdegradationbytheproteasome(Bysimilarity).PHF-taucanbemodifiedbythreedifferentformsofpolyubiquitination."Lys-48"-linkedpolyubiquitinationisthemajorform,"Lys-6"-linkedand"Lys-11"-linkedpolyubiquitinationalsooccur.&GlycationofPHF-tau,butnotnormalbraintau.Glycationisanon-enzymaticpost-translationalmodificationthatinvolvesacovalentlinkagebetweenasugarandanaminogroupofaproteinmoleculeformingketoamine.Subsequentoxidation,fragmentationand/orcross-linkingofketoamineleadstotheproductionofadvancedglycationendproducts(AGES).GlycationmayplayaroleinstabilizingPHFaggregationleadingtotangleformationinAD.
      DISEASE:SwissProt:P10636#InAlzheimerdisease,theneuronalcytoskeletoninthebrainisprogressivelydisruptedandreplacedbytanglesofpairedhelicalfilaments(PHF)andstraightfilaments,mainlycomposedofhyperphosphorylatedformsofTAU(PHF-TAUorADP-TAU).&DefectsinMAPTareacauseoffrontotemporaldementiaandparkinsonismlinkedtochromosome17(FTDP17)[MIM:600274,172700];alsocalledfrontotemporaldementia(FTD)orhistoricallytermedPickcomplex.Thisformoffrontotemporaldementiaischaracterizedbypreseniledementiawithbehavioralchanges,deteriorationofcognitivecapacitiesandlossofmemory.Insomecases,parkinsoniansymptomsareprominent.Neuropathologicalchangesincludefrontotemporalatrophyoftenassociatedwithatrophyofthebasalganglia,substantianigra,amygdala.Inmostcases,proteintaudepositsarefoundinglialcellsand/orneurons.&DefectsinMAPTareacauseofpallido-ponto-nigraldegeneration(PPND)[MIM:168610].Theclinicalfeaturesincludeocularmotilityabnormalities,dystoniaandurinaryincontinence,besidesprogressiveparkinsonismanddementia.&DefectsinMAPTareacauseofcorticobasaldegeneration(CBD).Itismarkedbyextrapyramidalsignsandapraxiaandcanbeassociatedwithmemoryloss.NeuropathologicfeaturesmayoverlapAlzheimerdisease,progressivesupranuclearpalsy,andParkinsondisease.&DefectsinMAPTareacauseofprogressivesupranuclearpalsy(PSP)[MIM:601104,260540];alsoknownasSteele-Richardson-Olszewskisyndrome.PSPischaracterizedbyakinetic-rigidsyndrome,supranucleargazepalsy,pyramidaltractdysfunction,pseudobulbarsignsandcognitivecapacitiesdeterioration.Neurofibrillarytanglesandgliosisbutnoamyloidplaquesarefoundindiseasedbrains.Mostcasesappeartobesporadic,withasignificantassociationwithacommonhaplotypeincludingtheMAPTgeneandtheflankingregions.Familialcasesshowanautosomaldominantpatternoftransmissionwithincompletepenetrance;geneticanalysisofafewcasesshowedtheoccurrenceoftaumutations,includingadeletionofAsn-613.&DefectsinMAPTmaybeacauseofhereditarydysphasicdisinhibitiondementia(HDDD)[MIM:607485].HDDDisafrontotemporaldementiacharacterizedbyprogressivecognitivedeficitswithmemorylossandpersonalitychanges,severedysphasicdisturbancesleadingtomutism,andhyperphagia.
      SIMILARITY:Contains4Tau/MAPrepeats.
      MolecularWeight5bands(52–68kDa)
      PhysicochemicalInformation
      Dimensions
      MaterialsInformation
      MaterialsInformation
    售后保障
    螞蟻淘生物188，秉承螞蟻淘一貫的嚴(yán)謹(jǐn)態(tài)度，由螞蟻淘公司專業(yè)人員負(fù)責(zé)品控、采購、物流、銷售、售后，保障正品優(yōu)質(zhì)。以“快速好省，為科研提供好產(chǎn)品、好價格”為理念，直接鏈接原廠家，從全國各地原制造商嚴(yán)格挑選188款科研精品，剔除品牌溢價，188生物新電商，把好的產(chǎn)品帶給科研！? 力求給你最優(yōu)質(zhì)的商品。
  • Q：生物188產(chǎn)品正品保障嗎？
    A：生物188質(zhì)量把控人員具有十年的從業(yè)經(jīng)驗(yàn)，在業(yè)界享有良好的口碑；自營商城，直接從廠家采購， 自己的團(tuán)隊(duì)負(fù)責(zé)國際物流和清關(guān)，中間沒有第三方，所有流程嚴(yán)格把控，100%保證正品，假一罰十。

    Q：下單后可以修改訂單嗎？
    A：下單后的商品付款之前可以修改；訂單付款成功，需要聯(lián)系我們客服進(jìn)行修改；客服電話：4000-520-616

    Q：可以開發(fā)票嗎？
    A：本網(wǎng)站所售商品都是正規(guī)清關(guān)，均開具16%正規(guī)發(fā)票，發(fā)票金額含配送費(fèi)金額，另有說明的除外。

    Q：商品幾天可以發(fā)貨？
    A：生物188商品，全部現(xiàn)貨銷售，付款后即可發(fā)貨,一般一周內(nèi)送達(dá)！

    Q：如何聯(lián)系商家？
    A：有任何問題夠可以電話咨詢我們，全國24小時免費(fèi)服務(wù)熱線：4000-520-616 或聯(lián)系我們的在線客服QQ：1570468124

    Q：收到的商品少了/發(fā)錯了怎么辦？
    A：同個訂單購買多個商品可能會分為一個以上包裹發(fā)出，可能不會同時送達(dá)，建議查看訂單詳情是否是 部分發(fā)貨狀態(tài)；如未收到，可聯(lián)系在線客服或者致電4000-520-616。

    Q：退換貨/維修需要多長時間？
    A：一般情況下，退貨處理周期為客戶收到產(chǎn)品一個月內(nèi)（以快遞公司顯示簽收時間為準(zhǔn)），包裝規(guī)格、 數(shù)量、品種不符，外觀毀損、短缺或缺陷，請?jiān)谑盏截?4小時內(nèi)申請退換貨；特殊商品以合同條款為準(zhǔn)。

何為188

極簡而嚴(yán)謹(jǐn)，我們僅銷售188款生物醫(yī)學(xué)科研用品，款款都是爆款；因?yàn)樯偎跃劢?，聚焦甄選每一款產(chǎn)品，聚焦服務(wù)每一位客戶!

關(guān)注我們 :

點(diǎn)擊QQ聯(lián)系我們
生物188微信

關(guān)注188微信公眾號

獲取最新優(yōu)惠活動通知